Development of a Phenotypic High-Content Assay to Identify Pharmacoperone Drugs for the Treatment of Primary Hyperoxaluria Type 1 by High-Throughput Screening

MLA

Jo Ann Janovick, et al. “Development of a Phenotypic High-Content Assay to Identify Pharmacoperone Drugs for the Treatment of Primary Hyperoxaluria Type 1 by High-Throughput Screening.” ASSAY and Drug Development Technologies, vol. 13, Feb. 2015, pp. 16–24. EBSCOhost, https://doi.org/10.1089/adt.2014.627.

APA

Jo Ann Janovick, Sonia Fargue, Louis Scampavia, Christopher J. Danpure, Yih-Tai Chen, David C. Smithson, Timothy P. Spicer, Franck Madoux, & P. Michael Conn. (2015). Development of a Phenotypic High-Content Assay to Identify Pharmacoperone Drugs for the Treatment of Primary Hyperoxaluria Type 1 by High-Throughput Screening. ASSAY and Drug Development Technologies, 13, 16–24. https://doi.org/10.1089/adt.2014.627

Chicago

Jo Ann Janovick, Sonia Fargue, Louis Scampavia, Christopher J. Danpure, Yih-Tai Chen, David C. Smithson, Timothy P. Spicer, Franck Madoux, and P. Michael Conn. 2015. “Development of a Phenotypic High-Content Assay to Identify Pharmacoperone Drugs for the Treatment of Primary Hyperoxaluria Type 1 by High-Throughput Screening.” ASSAY and Drug Development Technologies 13 (February): 16–24. doi:10.1089/adt.2014.627.